Enlivex Therapeutics Ltd. (ENLV) vs Scienture Holdings, Inc. (SCNX)
A side-by-side comparison of Enlivex Therapeutics Ltd. and Scienture Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ENLV
Enlivex Therapeutics Ltd.
$0.35HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
SCNX
Scienture Holdings, Inc.
$3.60HealthcareDelayed quote: Oct 6, 2026, 2:44 PM EDT
Total return — ENLV vs SCNX
growth of $100 · dividends reinvested · last 2yENLV -98.1% (-86.3%/yr)SCNX -98.0% (-85.9%/yr)SCNX compounded faster over this window
ENLV SCNX
ENLV vs SCNX: by the numbers
- •SCNX is the larger company ($6M vs $6M market cap).
- •Both run net losses; ENLV's is the smaller (0.00% vs -4620.92% net margin).
Metrics side by side
Valuation
| Metric | ENLV | SCNX |
|---|---|---|
| P/E ratio | 0.00 | N/A |
| P/S ratio | N/A | 7.12 |
| P/B ratio | 0.00 | 0.09 |
Profitability
| Metric | ENLV | SCNX |
|---|---|---|
| Gross margin | 0.00% | 76.80% |
| Operating margin | 0.00% | -3763.78% |
| Net margin | 0.00% | -4620.92% |
| ROE | 105.35% | -59.21% |
| ROIC | -0.32% | -15.99% |
Growth (annualized)
| Metric | ENLV | SCNX |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -42.69% |
| Total return CAGR (5Y) | -69.81% | N/A |
Go deeper
Dig into the metrics
Enlivex Therapeutics ROEScienture ROEEnlivex Therapeutics operating marginScienture operating marginEnlivex Therapeutics revenue growthScienture revenue growthEnlivex Therapeutics free cash flowScienture free cash flow
Enlivex Therapeutics & Scienture appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.